Skip to Main Content

Author Details

Teresa Ram??n y Cajal
Familial Cancer Clinic, Hospital Sant Pau
2000
93
27
PMIDPaper TitleJournal TitlePublished Year
38039887The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families.Breast2024
37133731SEOM clinical guideline on heritable TP53-related cancer syndrome (2022).Clin Transl Oncol2023
36948887p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.J Pathol Clin Res2023
37148499SEOM-GEICAM-SOLTI clinical guidelines in advanced breast cancer (2022).Clin Transl Oncol2023
37273149Correction to: SEOM-GEICAM-SOLTI clinical guidelines in advanced breast cancer (2022).Clin Transl Oncol2023
36972661Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers.Eur J Cancer2023
33157315Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome.Clin Gastroenterol Hepatol2022
35686103Cell Senescence-Related Pathways Are Enriched in Breast Cancer Patients With Late Toxicity After Radiotherapy and Low Radiation-Induced Lymphocyte Apoptosis.Front Oncol2022
34678156A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.Lancet Oncol2021
34454113Paired Somatic-Germline Testing of 15 Polyposis and Colorectal Cancer-Predisposing Genes Highlights the Role of APC Mosaicism in de Novo Familial Adenomatous Polyposis.J Mol Diagn2021
31220642Clinical and Pathological Characterization of Lynch-Like Syndrome.Clin Gastroenterol Hepatol2020
31889241SEOM clinical guidelines in hereditary breast and ovarian cancer (2019).Clin Transl Oncol2020
32006340SEOM clinical guideline thyroid cancer (2019).Clin Transl Oncol2020
33343622MicroRNA-1291 Is Associated With Locoregional Metastases in Patients With Early-Stage Breast Cancer.Front Genet2020
33167498Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Spain: Clinical and Genetic Characterization.Cancers (Basel)2020
32635641Comprehensive Constitutional Genetic and Epigenetic Characterization of Lynch-Like Individuals.Cancers (Basel)2020
32792570Role of POLE and POLD1 in familial cancer.Genet Med2020
32784934Risk of Cancer in Family Members of Patients with Lynch-Like Syndrome.Cancers (Basel)2020
32505560Presentation and Follow-up of Familial Adenomatous Polyposis: Differences Between APC and MUTYH Mutations.Cir Esp (Engl Ed)2020
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
32113160A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants.EBioMedicine2020
32325420Association of premenopausal risk-reducing salpingo-oophorectomy with breast cancer risk in BRCA1/2 mutation carriers: Maximising bias-reduction.Eur J Cancer2020
32462437Implications of Bariatric Surgery in Patients with Familial Adenomatous Polyposis Requiring Proctocolectomy with Ileal Pouch Anal Anastomosis.Obes Surg2020
30639730Validity and Reliability of the Decision Regret Scale in Cancer Patients Receiving Adjuvant Chemotherapy.J Pain Symptom Manage2019
31510873POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas.J Am Heart Assoc2019
31537406Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.Eur Urol2019
30761638Emotional functioning to screen for psychological distress in breast and colorectal cancer patients prior to adjuvant treatment initiation.Eur J Cancer Care (Engl)2019
29651672Factors associated with anxiety and depression in cancer patients prior to initiating adjuvant therapy.Clin Transl Oncol2018
29502561MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.Mayo Clin Proc2018
27048161Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma.Clin Transl Oncol2017
28985233Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM "El Álamo III" retrospective study.PLoS One2017
28853721The wide spectrum of POT1 gene variants correlates with multiple cancer types.Eur J Hum Genet2017
28687563Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC).Eur J Endocrinol2017
27704399Consensus on the management of advanced radioactive iodine-refractory differentiated thyroid cancer on behalf of the Spanish Society of Endocrinology Thyroid Cancer Working Group (GTSEEN) and Spanish Rare Cancer Working Group (GETHI).Clin Transl Oncol2017
26687366Consensus on management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI).Clin Transl Oncol2016
26601805Spanish consensus for the management of patients with advanced radioactive iodine refractory differentiated thyroid cancer.Endocrinol Nutr2016
26463438The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients.J Gynecol Oncol2016
27443449Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.Radiother Oncol2016
25398538Apoptosis for prediction of radiotherapy late toxicity: lymphocyte subset sensitivity and potential effect of TP53 Arg72Pro polymorphism.Apoptosis2015
26163143Mammographic density and breast cancer in women from high risk families.Breast Cancer Res2015
25830658Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.PLoS One2015
25849179Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.JAMA2015
25732322Consensus on the management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI).Endocrinol Nutr2015
25454820Deletion at 6q24.2-26 predicts longer survival of high-grade serous epithelial ovarian cancer patients.Mol Oncol2015
25583658Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma.Endocrinol Nutr2015
23530899Identification of a founder EPCAM deletion in Spanish Lynch syndrome families.Clin Genet2014
25379022Chromosome 17 centromere duplication and responsiveness to anthracycline-based neoadjuvant chemotherapy in breast cancer.Neoplasia2014
24953332Prevalence of germline MUTYH mutations among Lynch-like syndrome patients.Eur J Cancer2014
24484606Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.Eur Urol2014
24130102About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants.Int J Cancer2014
  • 1 - 50 of 93

Recommended Authors

Florentine S Hilbers
Netherlands Cancer Institute
Career Start Year 2012
Number of shared co-authors 14
Sarah M Nielsen
Invitae Corporation
Career Start Year 2011
Number of shared co-authors 26
Eric C Polley
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 32
Kasmintan A Schrader
University of British Columbia
Career Start Year 2005
Number of shared co-authors 31
Larissa A Korde
Clinical Investigations Branch, National Cancer Institute
Career Start Year 2004
Number of shared co-authors 7
Liying Zhang
The Fifth Affiliated Hospital, Sun Yat-sen University
Career Start Year 2004
Number of shared co-authors 35
Hisani N Horne
National Cancer Institute
Career Start Year 2004
Number of shared co-authors 18
Xiaohong R Yang
National Cancer Institute
Career Start Year 2003
Number of shared co-authors 55
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 2
Jonine D Figueroa
The Usher Institute, The University of Edinburgh
Career Start Year 2001
Number of shared co-authors 87
Richard B Schwab
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 0
Kathryn Alsop
Peter MacCallum Cancer Centre
Career Start Year 1998
Number of shared co-authors 81
Rebecca Sutphen
College of Medicine, University of South Florida
Career Start Year 1995
Number of shared co-authors 98
Montserrat Garcia-Closas
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 121
Simone Maistro
Instituto do Cancer do Estado de Sao Paulo, Universidade de Sao Paulo
Career Start Year 1994
Number of shared co-authors 1
Maria Aparecida Azevedo Koike Folgueira
Center for Translational Oncology, Cancer Institute of the State of Sao Paulo - ICESP
Career Start Year 1993
Number of shared co-authors 3
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 55
Peggy L Porter
Fred Hutchinson Cancer Research Center
Career Start Year 1991
Number of shared co-authors 8
Clare Turnbull
Institute of Cancer Research
Career Start Year 1991
Number of shared co-authors 65
Paul J van Diest
University Medical Center Utrecht
Career Start Year 1989
Number of shared co-authors 6
James M Ford
Stanford University
Career Start Year 1989
Number of shared co-authors 12
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 84
Jeffery P Struewing
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1988
Number of shared co-authors 30
Hoda Anton-Culver
University of California irvine
Career Start Year 1988
Number of shared co-authors 110
Barbara L Weber
Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania
Career Start Year 1988
Number of shared co-authors 48
Alvaro N A Monteiro
H. Lee Moffitt Cancer Center & Research Institute
Career Start Year 1985
Number of shared co-authors 96
Laura J Van't Veer
University of California San Francisco
Career Start Year 1984
Number of shared co-authors 75
Vessela N Kristensen
Faculty of Clinical Medicine, University of Oslo
Career Start Year 1983
Number of shared co-authors 91
Janet E Olson
Mayo Clinic
Career Start Year 1979
Number of shared co-authors 93
Anne-Lise B??rresen-Dale
Institute for Cancer Research, Oslo University Hospital
Career Start Year 1972
Number of shared co-authors 74

Collaborators

Javier Ben??tez
Instituto de Salud Carlos III
Co-authored papers 24
Ana Osorio
Familial Cancer Clinical Unit, Spanish National Cancer Research Centre
Co-authored papers 17
Jan Lubinski
Pomeranian Medical University
Co-authored papers 12
Susan M Domchek
Co-authored papers 11
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers 10
Cezary Cybulski
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 9
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 9
Katherine L Nathanson
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Co-authored papers 8
Douglas F Easton
University of Cambridge
Co-authored papers 8
Mar??a J Garc??a
Spanish National Cancer Research Centre (CNIO)
Co-authored papers 8
Louise Izatt
Guy's and St Thomas' NHS Foundation Trust
Co-authored papers 7
Fergus J Couch
Mayo Clinic
Co-authored papers 7
Irene L Andrulis
University of Toronto
Co-authored papers 7
Jacek Gronwald
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 7
Susana Hernando
University Hospital Fundacion Alcorcon
Co-authored papers 6
Paolo Radice
Ospedale Circolo e Fondazione Macchi
Co-authored papers 6
Gustavo C Rodriguez
Clinica Quirurgica 2 (Surgical Clinic 2), Hospital Maciel
Co-authored papers 6
Timothy R Rebbeck
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
Co-authored papers 6
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers 6
Christi J van Asperen
Leiden University Medical Center
Co-authored papers 6
Amanda B Spurdle
QIMR Berghofer Medical Research Institute
Co-authored papers 6
Noralane M Lindor
Mayo Clinic
Co-authored papers 5
Mary Beth Terry
Co-authored papers 5
Sue Healey
QIMR Berghofer Medical Research Institute
Co-authored papers 5
Jenny Lester
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 5
Esther M John
Co-authored papers 5
Jes??s Garc??a-Donas
HM Hospitales-Centro Integral Oncologico Clara Campal
Co-authored papers 5
Jonathan Beesley
QIMR Berghofer Medical Research Institute
Co-authored papers 5
David E Goldgar
University of Utah
Co-authored papers 5
Xiaoqing Chen
QIMR Berghofer Medical Research Institute
Co-authored papers 5
Release 1.2